Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer

Diagnosing, treating and managing breast cancer during COVID-19

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC

Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer

An oncologist's experience of managing breast cancer during the COVID-19 outbreak

COVID-19: The situation in Peru and managing radiotherapy patients

COVID-19: The management of coronavirus patients with cancer, examples from Italy

Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer

How can we implement breast cancer screening India?

Screening and early detection of breast cancer in India